"$CINGW $CING Cingulate Provides 2022 Clinical Plan for CTx-1301, an Investigational Medication for Attention Deficit/Hyperactivity Disorder (ADHD) https://t.co/tsmyjSrEAV"

dexmethylphenidate tri-modal release (CTx-1301) - Cingulate Therap

Feb 8, 2022